Literature DB >> 12434154

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

J D Carpten1, C M Robbins, A Villablanca, L Forsberg, S Presciuttini, J Bailey-Wilson, W F Simonds, E M Gillanders, A M Kennedy, J D Chen, S K Agarwal, R Sood, M P Jones, T Y Moses, C Haven, D Petillo, P D Leotlela, B Harding, D Cameron, A A Pannett, A Höög, H Heath, L A James-Newton, B Robinson, R J Zarbo, B M Cavaco, W Wassif, N D Perrier, I B Rosen, U Kristoffersson, P D Turnpenny, L-O Farnebo, G M Besser, C E Jackson, H Morreau, J M Trent, R V Thakker, S J Marx, B T Teh, C Larsson, M R Hobbs.   

Abstract

We report here the identification of a gene associated with the hyperparathyroidism-jaw tumor (HPT-JT) syndrome. A single locus associated with HPT-JT (HRPT2) was previously mapped to chromosomal region 1q25-q32. We refined this region to a critical interval of 12 cM by genotyping in 26 affected kindreds. Using a positional candidate approach, we identified thirteen different heterozygous, germline, inactivating mutations in a single gene in fourteen families with HPT-JT. The proposed role of HRPT2 as a tumor suppressor was supported by mutation screening in 48 parathyroid adenomas with cystic features, which identified three somatic inactivating mutations, all located in exon 1. None of these mutations were detected in normal controls, and all were predicted to cause deficient or impaired protein function. HRPT2 is a ubiquitously expressed, evolutionarily conserved gene encoding a predicted protein of 531 amino acids, for which we propose the name parafibromin. Our findings suggest that HRPT2 is a tumor-suppressor gene, the inactivation of which is directly involved in predisposition to HPT-JT and in development of some sporadic parathyroid tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434154     DOI: 10.1038/ng1048

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  203 in total

Review 1.  Genetics of endocrine and metabolic disorders: parathyroid.

Authors:  R V Thakker
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

2.  Cdc73 subunit of Paf1 complex contains C-terminal Ras-like domain that promotes association of Paf1 complex with chromatin.

Authors:  Christopher G Amrich; Christopher P Davis; Walter P Rogal; Margaret K Shirra; Annie Heroux; Richard G Gardner; Karen M Arndt; Andrew P VanDemark
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 3.  Hypercalcemia in children and adolescents.

Authors:  Steven A Lietman; Emily L Germain-Lee; Michael A Levine
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

Review 4.  Parathyroid cancer.

Authors:  Fiona McClenaghan; Yassar A Qureshi
Journal:  Gland Surg       Date:  2015-08

Review 5.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

6.  The PAF1 complex component Leo1 is essential for cardiac and neural crest development in zebrafish.

Authors:  Catherine T Nguyen; Adam Langenbacher; Michael Hsieh; Jau-Nian Chen
Journal:  Dev Biol       Date:  2010-02-21       Impact factor: 3.582

7.  Immunohistochemical assessment of parafibromin in mouse and human tissues.

Authors:  Andrea Porzionato; Veronica Macchi; Luisa Barzon; Giulia Masi; Maurizio Iacobone; Anna Parenti; Giorgio Palù; Raffaele De Caro
Journal:  J Anat       Date:  2006-12       Impact factor: 2.610

8.  Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.

Authors:  J-H Zhang; L M Panicker; E M Seigneur; L Lin; C D House; W Morgan; W C Chen; H Mehta; M Haj-Ali; Z-X Yu; W F Simonds
Journal:  Cell Death Differ       Date:  2010-03-26       Impact factor: 15.828

9.  CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.

Authors:  Cathy D Vocke; Christopher J Ricketts; Mark W Ball; Laura S Schmidt; Adam R Metwalli; Lindsay A Middelton; J Keith Killian; Javed Khan; Paul S Meltzer; William F Simonds; Maria J Merino; W Marston Linehan
Journal:  Urology       Date:  2018-11-16       Impact factor: 2.649

Review 10.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.